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ABSTRACT 
Objective: The present study was designed to investigate the anti-melanoma activity of the ethyl acetate fraction of Lawsonia alba lam leaves (ELA) 
against B16F10 cells. 
Methods: Cytotoxicity of ELA on B16F10 cells was determined by MTT assay and supported with the morphology of apoptotic and necrotic cells 
under phase-contrast microscope, fluorescence microscopy with AO/EtBr, confocal microscopy with PI, Agarose gel electrophoresis and Annexin V-
FITC/PI staining, mitochondrial membrane potential and cell cycle arrest by FACS was also performed on B16F10 cells.  
Results: Cytotoxic effect of ELA on B16F10 melanoma cell was confirmed by MTT assay with an IC50
Conclusion: Ethyl acetate fraction of Lawsonia alba L. leaves possesses potent apoptotic activity against B16F10 cells. 
 value of 14.10μg/ml. Morphological study 
showed arrays of both the nuclear changes including chromatin condensation and apoptotic body formation indicating that the treatment with ELA 
and 5-Fluorouracil (standard) causes apoptotic changes in the melanoma cells compared to the untreated control. Agarose gel electrophoresis study 
showed fragmented DNA in the form of ladder. The depolarization of mitochondrial membrane potential was confirmed. Flow cytometric analysis 
showed appreciable number of cells in early apoptotic stage. The cells were arrested mostly in G0/G1 phase of cell cycle.  
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Cancer is the cell proliferation independent of growth factor regulation 
with apoptosis resistance and angiogenesis, leading to the disruption 
of homeostatic condition therapy to tumorigenesis. One of the forms of 
cancer i.e. malignant melanoma of the skin is the most frequent cause 
of mortality from skin cancer and approximately 20-25% of patients 
with malignant melanoma die of metastatic disease. Melanoma is an 
aggressive and refractory cancer derived from melanocytes [1]. The 
incidence of melanoma has been continuously increasing worldwide 
and becoming a huge public health issue [2]. The standard means of 
treating melanoma include surgery, radiation therapy, and 
chemotherapy [3]. (The treatment of melanoma disease largely 
depends upon early diagnosis [4]. Drug resistance in melanoma mainly 
occurred through dysregulation of apoptosis, whereas drug transport, 
detoxification, and enhanced DNA repair may also exert a function [5]. 
Henceforth, induction of apoptosis deliberated the major target of anti-
cancer chemotherapeutic strategies for melanoma [6]. 
Lawsonia alba (Lythraceae) commonly known as Henna is widely 
known for treating various ailments in folklore medicine. Essentially, it 
is a very common plant with flourishing medicinal properties 
including anti-microbial [7], antimalarial [8]. Our previous study on L. 
alba reported its hepatoprotective effects along with anti-oxidant 
property [9]. Amino derivatives of lawsone and lapachol were 
identified, showing the cytotoxicity against Ehrlich carcinoma and 
human K562 (leukemia cells). Henna when applied topically on the 
back skin in the UV-B initiated/TPA promoted and per-oxy-nitrite 
initiated/TPA promoted mouse skin carcinogenesis models antitumor 
activities [10]. In this study, we investigated the effects of Lawsonia 
alba leaves in melanoma cells because of its increasing incidence and 
high fatality rate for skin tumors. The present investigation ELA is an 
approach to study the apoptosis-inducing activity of the active fraction 
from Lawsonia alba leaves against B16F10 melanoma cell lines. 
MATERIALS AND METHODS 
Chemicals and reagents 
DMEM, fetal bovine serum(FBS), trypsin (Gibco, USA), 5-Fluorouracil 
(Sun Pharma), penicillin-streptomycin (Biowest, Germany), 
gentamycin (Nicholas, India), HEPES, L-glutamine, MTT, acridine 
orange, ethidium bromide, agarose (Puregene), proteinase k (SRL), 
Annexin-V FITC (apoptosis kit), RNase, Propidium Iodide, JC-1 
(Sigma), DMSO, Ethyl acetate (Merck). All other chemicals of 
analytical grade were procured locally. 
Cell line 
B16F10 cells were obtained from the National Facility for Animal 
Tissue and Cell Culture, Pune, India. The B16F10cells were cultured 
and routinely maintained in DMEM. The medium was supplemented 
with 10% heat inactivated fetal bovine serum (FBS), penicillin (100 
units/ml), streptomycin (100μg/ml), gentamycin (100μg/ml) and 
incubated at 37 °C in a humidified atmosphere containing 5% CO2 
inside a CO2 incubator. 
Collection and identification of plant specimen 
Lawsonia alba Lam. leaves were collected from Ranchi, Jharkhand and 
identified by Dr. V. P. Prasad, Scientist-D, Central National Herbarium, 
Botanical Survey of India, Shibpur, Howrah, West Bengal. The 
specimen authentication no. is CNH/Tech. П/2014/75/158. The 
preparation of the plant extract was described previously [9]. The 
methanolic extract of Lawsonia alba was further fractionated by 
separating funnel using Ethyl acetate. Removal of the solvent in a 
rotary evaporator (BUCHI R-200) yielded 750 mg of the ELA fraction. 
Cytotoxicity study by MTT assay 
For evaluation of the cytotoxic effect of ELA against melanoma cells 
MTT colourimetric assay was performed [11]. B16F10 cells in the log 
phase were cultured in 96-well plate and treated with different 
concentrations of ELA (1 mg/ml) for 24, 48 and 72 h. Cytotoxicity was 
measured using 3-(4, 5-dimethylthiazol-2-yl)-2 and 5-
diphenyltetrazolium bromide (MTT) assay. Standard drug 5-FU 
(0.087µg/ml) treated cells served as positive control [12]. The 
absorbance of each well was observed at a wavelength of 570 nm by 
microplate manager (Reader type Model 680 XR Bio-Rad laboratories 
lnc.) The IC50 value of ELA was determined for B16F10 cells. 
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Cell morphology assessment 
To investigate the effect of ELA on cell morphology 1 × 106 cells 
(B16F10) were seeded in DMEM media supplemented with 10% FBS. 
24h post adherence, the cells were treated with IC50 dose of ELA and 
anti-cancer drug 5-Fluorouracil. The cells were then observed under a 
light microscope (Leica Microscope) at a magnification of 40X. 
AO-EtBr staining 
The morphological changes of apoptosis were evaluated by fluorescence 
microscopy [13]. B16F10 melanoma cells (1x106) were cultured in 
coverslip in a small petri plate and allowed to grow for 24 h and another 
petri plate was kept as control. After 24 h cells were treated with IC50 
dose of ELA, 5-Fluorouracil and control plate was left untreated. After 
that plates were kept in a humified atmosphere with 5%  and C 
temperature for 18 h. After 18 h the cells adhered to the coverslip were 
washed with PBS and stained with 10 µl of acridine orange and ethidium 
bromide in a ratio of 1:1. Then the coverslips were mounted on clear 
slides and observed under a fluorescence microscope for the 
morphological determination of the cells undergoing apoptosis.  
Propidium iodide staining 
Propidium iodide stain was used to examine the nuclear 
fragmentation. B16F10 cells in log phase were treated with IC50 
dose of ELA and 5-FU for 24 h. After 24 h the control and ELA 
treated cells were harvested and washed with ice cold PBS. The cells 
were then stained with 10μg/ml of propidium iodide for 5 min. The 
cells were mounted on slides to observe the differences in nuclear 
morphology between untreated and ELA treated B16F10 cells under 
a confocal laser scanning microscope (Leica TCS-SP2 system, Leica 
Microsystem, Heidelberg, Germany) installed with an inverted 
microscope [Leica DM-7RB]. Images for propidium iodide were 
acquired from argon/krypton laser and UV laser line using 590 nm 
long pass filter for propidium iodide for images [14].  
DNA fragmentation study  
To confirm the apoptotic mode of cell death, DNA fragmentation 
assay was performed [15]. B16F10 cells (1x106) were treated with 
IC50 
B16F10 (1x10
dose with ELA and standard anti-cancer drug 5-FU for 24 h. The 
harvested cells were washed with PBS and re-suspended in lysis 
buffer, proteinase-k was added and lysis was initiated by incubation 
at 50 °C for 1hr at 37 °C overnight respectively. DNA fractionation 
was done following the general phenol-chloroform fractionation 
procedure. The isolated DNA samples were mixed with loading dye 
and subjected to 1% agarose gel electrophoresis for overnight at 
20V using ethidium-bromide. DNA fragmentation was observed in 
UV transilluminator (GENEI, Bangalore Genei Pvt. Ltd.) 
Mitochondrial membrane potential by flow cytometry 
6) cells were treated with ELA (1/2IC50
Apoptosis assay by flow cytometric analysis 
 dose and) for 
18 h to assay the mitochondrial membrane potential activity of cell 
in a flow cytometry. Cells were washed with PBS, pelleted down and 
dissolved in prewarmed PBS.200 µM JC-1 stain was added and the 
samples were incubated at 37 °C for 15 min. Shift in the 
mitochondrial membrane potential was determined by FACS 
(Becton Dickinson FACS Fortessa 4 laser Cytometer), fluorescence 
detector equipped with 488 nm argon laser light source and 623 nm 
band pass filter (linear scale) with the help of BD FACS Diva 
software (Becton Dickinson). 
To verify apoptosis in B16F10 treated cells, Annexin V–FITC assay 
was performed [16]. Flow cytometric analysis was done by 
performing dot plot assay to investigate the type of cell death 
induced by ELA. Exponentially growing cells were seeded and 
exposed to IC50 dose of 5-FU and ELA for 18 h. The cell pellets were 
washed with Annexin-FITC binding buffer provided in apoptosis kit 
(Sigma) and stained with propidium iodide. All data were taken by 
Becton-Dickinson FACS LSR Fortessa 4 laser Cytometer was taken 
using 488 nm excitation and band pass filters of 530/30 nm (for 
FITC detection) and 585/42 nm (for PI detection). Live statistics 
were used to align the X and Y mean values of the Annexin-V FITC or 
PI stained quadrant populations by compensation. Data analysis was 
performed by BD FACS Diva software program. 
Cell cycle arrest by flow cytometry 
B16F10 (1x106) cells were treated with 5-FU and ELA (IC50
RESULTS 
 dose) for 
18 h to assay the stage of cell cycle arrest in a flow cytometry. Cells 
were washed with PBS, fixed with cold methanol. Then, they were 
resuspended in cold PBS and kept at 4 °C for 90 min. Cells were 
pelleted down, dissolved in cold PBS, treated with RNase for 30 min 
at 37 °C and stained with propidium iodide and kept in dark for 15 
min. Cell cycle phase distribution of nuclear DNA was determined by 
FACS (Becton Dickinson FACS Fortessa 4 laser Cytometer), 
fluorescence detector equipped with 488 nm argon laser light source 
and 623 nm bandpass filter (linear scale) with the help of BD FACS 
Diva software (Becton Dickinson). 
Statistical analysis 
The data were analysed statistically using one-way ANOVA followed 
by Dunnet’s t-test. The data were expressed as mean±SEM. “P” value 
less than 0.05 implied significance. Values were expressed as mean 
*P<0.05, when compared to control. 
Cytotoxic potential 
MTT assay revealed significant reduction in cell proliferation in a 
time and concentration-dependent manner upon treatment with 
ELA at the concentration of 10μg, 25μg, 50μg, 100µg and 200µg for 
24, 48 and 72 h in B16F10 cell line. The IC50
 
 value of ELA for B16F10 
cell line was found to be 14.10 μg/ml. 
 
Fig. 1: MTT assay for 24, 48 and 72 h with different concentrations of ELA on B16F10 cells. The data were expressed as mean±SEM. “P” 
value less than 0.05 implied significance, values were expressed as mean *P<0.05, when compared to control 
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Cell morphology monitoring by light microscopy 
Light microscopic images clearly show membrane disintegration of 
ELA treated B16F10 cells compared to that of untreated control 
cells.  
Morphological characterization by AO/EtBr staining 
Acridine orange and ethidium bromide stained B16F10 melanoma 
cells revealed nuclear chromatin condensation and apoptotic body 
formation thereby indicating the occurrence of apoptosis. 
 
 
Fig. 2: (A) representslight microscopic images of control cells with intact cell membrane integrity. (B) and (C) represent cells treated with 
IC50 dose of ELA and 5-FU which show cell shrinkage and membrane disintegration 
 
 
Fig. 3: Fluorescence microscopic images of B16F10 melanoma cells stained with acridine orange and ethidium bromide in 1:1 ratio. (A) 
represents untreated control cells with intact nuclei that exhibit green fluorescence. (B) and (C) represent cells treated with IC50 dose of 
ELA and 5-FU. Both Fig. B and C show distinct cell shrinkage, chromatin condensation, nuclear fragmentation and membrane 
disintegration that are the hallmark of apoptosis 
 
Propidium iodide staining by confocal microscope 
Propidium iodide stained B16F10 skin melanoma cells revealed the 
presence of apoptotic bodies in the form of nuclear fragmentation in 
cells as compared to the untreated control cells. Nuclear chromatin 




Fig. 4: Confocal microscopic images of B16F10 melanoma cells stained with Propidium iodide. A, B and C represent control, ELA and 5-FU 
(IC50 
 
dose) treated cells. Control cells show intact membrane integrity whereas ELA and 5-FU treated cells show condensed chromatin 
and fragmented nuclei that confirm the generation of apoptotic bodies 
Detection of DNA fragmentation  
The gel pattern of DNA samples isolated from untreated control 
melanoma cells showed an intact DNA band whereas gel pattern of 
B16F10 cells treated with IC 50 
Depolarization of mitochondrial membrane potential 
dose of 5-FU and ELA showed 
degraded DNA bands in the form of ladder. These observations 
confirmed apoptosis induction upon treatment with ELA in 
melanoma cells. 
Depolarization in mitochondrial membrane potential was studied by 
staining treated and untreated cells with JC1 dye. The depolarization 
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led to a shift from red to green fluorescence leading to the release of 
Cytochrome C. A significant shift of 11.7% and 30.2% in the 
mitochondrial membrane potential from red to green fluorescence 
was observed when B16F10 cells were treated with the 1/2 IC50 
dose and IC50
For the detection of apoptosis by flow cytometric analysis, double 
labelling technique, using Annexin V FITC and propidium iodide, was 
utilized. Lower left (LL) quadrant (Annexin V-/PI-) depicted the 
population of live cells, lower right quadrant (LR) (Annexin V+/PI-) 
was regarded as the cell population at early apoptotic stage, upper 
right (UR) quadrant (Annexin V+/PI+) represented the cell 
population at late apoptotic stage and extreme upper right (UR) and 
upper left (UL) quadrant (Annexin V-/PI+) was considered as 
necrotic cell population. Flow cytometric data analysis revealed that 
after treatment with 1/2 IC
 dose of ELA for 18 h respectively. 
Detection of apoptosis by flow cytometric analysis 
50dose and IC50dose of ELA for 18 h, 
11.9% and 16.4% B16F10 cells were in the LR quadrant compared 
to 4.2% control cells indicating early apoptosis. 
 
Fig. 5: DNA fragmentation by Agarose gel electrophoresis assay. 
Lane 1 indicates control cells, lane 2 and 3 indicate 5-FU and 
ELA treated B16F10 cells 
 
 
Fig. 6: Flow cytometric analysis of Mitochondrial membrane potential on B16F10 cells in both control (A) and ELA 1/2 IC50 (B) and IC50 












B16F10 cells undergoing early …
B16F10 cells undergoing late …
 
Fig. 7: Detection of apoptosis by Flow cytometric analysis. Control, ELA 1/2 IC50 and IC50 dose treated cells after 18 h treatment. Staining 
was done with Annexin V FITC and Propidium iodide. Dual parameter dot plot of FITC-fluorescence (x-axis) vs. PI fluorescence (y-axis) 
shows logarithmic intensity 
 
Cell cycle arrest by flow cytometric analysis 
Flow cytometric analysis of B16F10 cells when treated with 1/2IC50 
and IC50
 
 dose of ELA for 18 h revealed a peak change in the G0/G1 
phase. DNA content of 59.8% and 63.3% were obtained for 18 h 
respectively in G0/G1 phase. These results confirmed ELA treatment 
arrested cell cycle mostly at G0/G1 phase. 
 
Fig. 8: Flow cytometric analysis of cell cycle phase distribution in control and ELA 1/2 IC50 (B) and IC50 treated cells (C) after 18 h 
treatment. Histograms represent various contents of DNA with the actual number of cells (x-axis denotes the fluorescence intensity of PE-
Texas red and y-axis denotes count) 
Besra et al. 
Int J Pharm Pharm Sci, Vol 10, Issue 5, 96-101 
100 
DISCUSSION 
Several natural products and their analogues have been identified as 
potent anti-cancer agents and the identification of anti-cancer 
property of various plants is being unravelled in a significant 
manner. Our results clearly indicated that Ethyl acetate fraction of 
Lawsonia alba leaves (ELA) exert cytotoxicity on B16F10 melanoma 
cells through apoptosis. Its anti-melanoma effect was also compared 
with 5-Fluorouracil, a standard anti-cancer drug. ELA renders anti-
cancer property against B16F10 cells which were supported by the 
morphological studies and depolarization of the mitochondrial 
membrane potential thereby leading to apoptosis. These outcomes 
represent reliable evidence supporting the administration of ELA in 
melanoma treatment in vitro.  
MTT assay revealed a significant reduction in cell proliferation in a 
time and concentration-dependent manner upon treatment with 
ELA in B16F10 cell line. The IC50 value of ELA for B16F10 cell line 
was found to be 14.10 μg/ml. (fig. 1) under phase contrast 
microscope, the cells in the control group were observed to be 
spindle-shaped, in close contact with neighbouring cells, and 
adhered to the surface (fig. 2). Post-treatment with ELA, there was a 
change in the morphology marked by cell shrinkage, with rounded 
or irregular cell outlines and many vacuole-like structures in the 
cytoplasm (fig. 1B, C). Morphological changes of B16F10 cells 
treated with ELA and 5-FU for 24 h at IC50
JC-1 is a novel cationic carbocyanine dye that accumulates in 
mitochondria. The loss of mitochondrial membrane potential is a 
hallmark of apoptosis. In healthy cells, the dye stains the 
mitochondria bright red. The negative charge established by the 
intact mitochondria membrane potential allows the lipoliphic dye 
bearing a delocalized positive charge, to enter the mitochondrial 
matrix where it accumulates. In apoptotic cells, the mitochondrial 
membrane potential collapses, and the JC-1 cannot accumulate 
within the mitochondria. In these cells, JC-1 remains in the 
cytoplasm in a green fluorescent monomeric form. Apoptotic cells 
showing primarily green fluorescence are easily differentiated from 
healthy cells which show red fluorescence. JC-1 staining of B16F10 
cells treated with ELA shows a significant shift in the 
transmembrane potential from red to green fluorescence. Hence, our 
data suggest a change in the transmembrane potential, thereby 
triggering apoptosis (fig. 6). Quantitative estimation of cells 
undergoing early and late apoptosis was performed by Annexin V-
FITC staining. The translocation of phosphatidylserine molecules to 
the outer surface of the cell allows determination of apoptosis when 
Annexin-V labeled with FITC is applied to the cell environment [19]. 
Annexin V-PI-considered as viable cells, while Annexin V+/PI-
staining patterns showed early apoptotic cells; whereas Annexin 
V+/PI+ exhibited late apoptotic cells due to a loss of plasma 
membrane integrity and Annexin V-FITC-/PI+ was considered as 
necrotic cells [20, 21]. B16F10 cells when treated with 5-FU and IC
 were also analyzed by 
dual acridine orange/ethidium bromide (AO/EB) fluorescent 
staining. Acridine orange and Ethidium bromide are two cationic 
fluorescent DNA intercalating dyes. AO stains the viable cells green 
whereas EtBr stains the apoptotic cells orange, fragmented green 
nucleus represent early apoptotic cells, and orange/green dots of 
condensed nuclei indicate late apoptosis [17]. Cells treated with ELA 
upon AO/EtBr staining exhibited characteristic changes of apoptosis 
e. g. cell shrinkage, nuclear condensation, fragmentation and 
formation of apoptotic bodies (fig. 3). In order to aid the nuclear 
visualization, cells were stained with PI and nuclear morphology 
changes were observed under the confocal microscope. Cells treated 
with ELA showed nuclear margination and chromatin condensation, 
membrane blebbing, nuclear fragmentation and membrane loss (fig. 
4). Fragmentation of chromatin to units of single or multiple 
nucleosomes that form the nucleosomal DNA ladder in agarose gel is 
an established hallmark of programmed cell death or apoptosis [18]. 
DNA fragmentation as detected by agarose gel assay suggests 
induction of apoptosis following exposure to ELA (fig. 5).  
50 
In conclusion, the present study demonstrated that ELA could inhibit 
the proliferation of B16F10 cell line in vitro and induce apoptosis by 
causing a shift in the mitochondrial membrane potential. Therefore, 
the results from this study provide critically important experimental 
facts to suggest that ELA may be a potential therapeutic agent for 
treating melanoma. 
dose of ELA demonstrated cells undergoing early apoptosis (fig. 7). 
Cell cycle and apoptosis together play an important role in the 
sensitivity of cancer cells. Cell cycle checkpoints are important 
regulatory mechanisms that ensure the proper passage of cells 
through the cell cycle. The G2/M and G1/S checkpoints are critical in 
maintaining DNA integrity and essential in executing the proper cell 
cycle events. It was known that loss of regulation of these 
checkpoints resulted into transformation and progression of cancer 
cells. The mode of cell death of cancer cells by ELA predominately 
followed apoptosis. A possible arrest of the G0/G1 phase might have 
triggered apoptosis (fig. 8). 
CONCLUSION 
Ethyl acetate fraction of Lawsonia alba demonstrated dose-dependent 
anti-proliferative properties in B16F10 melanoma cells. We also 
observed membrane blebbing chromatin condensation, membrane loss 
and DNA fragmentation in the form of the ladder in ELA treated B16F10 
cells. The morphological characteristics indicated the induction of 
apoptosis. Post ELA treatment, the transmembrane potential shift from 
red to green also triggered apoptosis. Annexin V-FITC staining 
demonstrated cells undergoing early apoptosis. Cell cycle study 
observed by flow cytometry revealed a possible arrest of the G0/G1 
phase, indicating this phase arrest might have triggered apoptosis. These 
results have important clinical implications as they suggest 
commendable anti-proliferative activities against B16F10 melanoma 
cells. Ethyl acetate fraction of Lawsonia alba can be considered as an 
effective adjuvant therapeutic agent. Further study of proteins involved 
in apoptosis will improve our findings and give useful results to establish 
Lawsonia alba as a novel drug against melanoma. 
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